Creative Planning’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-19,024
Closed -$273K – 4306
2026
Q1
$273K Sell
19,024
-315
-2% -$4.68K ﹤0.01% 3489
2025
Q4
$291K Buy
19,339
+4,872
+34% +$73.1K ﹤0.01% 3262
2025
Q3
$209K Buy
14,467
+3,773
+35% +$53.6K ﹤0.01% 3447
2025
Q2
$152K Sell
10,694
-95
-0.9% -$1.36K ﹤0.01% 3324
2025
Q1
$161K Sell
10,789
-1,049
-9% -$16.4K ﹤0.01% 3141
2024
Q4
$170K Buy
+11,838
New +$183K ﹤0.01% 3022
2021
Q2
– Sell
-25,250
Closed -$664K – 2131
2021
Q1
$664K Hold
25,250
– – ﹤0.01% 1258
2020
Q4
$723K Buy
25,250
+250
+1% +$6.65K ﹤0.01% 1111
2020
Q3
$596K Hold
25,000
– – ﹤0.01% 1048
2020
Q2
$523K Hold
25,000
– – ﹤0.01% 1009
2020
Q1
$448K Buy
+25,000
New +$482K ﹤0.01% 999

Other funds holding BMEZ

Creative Planning's BMEZ Position: Q2 2026 in Review

Creative Planning sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2026, closing a stake of 19,024 shares — an estimated $273K sold.

Creative Planning first reported a position in BMEZ in Q1 2020 and held it in 11 quarters. The position peaked at $723K in Q4 2020. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Creative Planning reported no remaining BlackRock Health Sciences Trust II position as of Q2 2026 after selling out during the quarter.
  • Creative Planning sold 19,024 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $273K.
  • Creative Planning first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and held it in 11 quarters.
  • Creative Planning's BlackRock Health Sciences Trust II position peaked at $723K in Q4 2020.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.